文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

低体温对大量输血患者结局的影响

The impact of hypothermia on outcomes in massively transfused patients.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在大量输血患者中,体温低于36°C时每降低1°C,24小时红细胞消耗增加10%,且入院低体温是24小时和30天死亡的独立预测因素。

该研究基于PROPPR试验中12家一级创伤中心预测需大量输血的患者,按急诊科到达后6小时内体温分为低体温组(<36°C)和正常体温组(36-38.5°C)。680例中590例有体温记录,399例发生低体温。多变量分析显示,体温低于36.0°C时每降低1°C,24小时红细胞消耗增加10%(发生率比0.90,95%CI 0.89-0.92,p<0.00);体温高于36°C时红细胞给药无关联。入院低体温是死亡的独立预测因素,24小时死亡调整OR为2.7(95%CI 1.7-4.5,p<0.00),30天死亡调整OR为1.8(95%CI 1.3-2.4,p<0.00)。作者认为这些发现支持在创伤患者中维持正常体温,并建议进一步研究大量输血期间降温或复温的影响。

要点

  • 在预测需大量输血的创伤患者中,急诊科到达后6小时内低体温(<36°C)者399/590例。
  • 体温低于36.0°C时每降低1°C,24小时红细胞消耗增加10%(发生率比0.90,95%CI 0.89-0.92,p<0.00)。
  • 体温高于36°C时,红细胞给药与体温无关联。
  • 入院低体温是24小时死亡的独立预测因素(调整OR 2.7,95%CI 1.7-4.5,p<0.00)。
  • 入院低体温是30天死亡的独立预测因素(调整OR 1.8,95%CI 1.3-2.4,p<0.00)。

适用人群与场景

  • 12家一级创伤中心中预测需大量输血的创伤患者,随机纳入PROPPR试验。
  • 分析人群为急诊科到达后6小时内测量过体温的患者(590/680例),分为低体温组(<36°C)和正常体温组(36-38.5°C)。

诊断标准与关键阈值

  • 低体温定义为急诊科到达后6小时内体温<36°C;正常体温定义为36-38.5°C。

研究设计与关键结果

  • 研究类型为PROPPR试验的二次分析,纳入12家一级创伤中心预测需大量输血的创伤患者680例,其中590例在急诊科到达后6小时内测量了体温,399例发生低体温。
  • 所有患者入院24小时内平均输注红细胞8.8单位(95%CI 7.9-9.6)。
  • 多变量分析(调整治疗臂、损伤严重度评分、机制、人口学特征、急诊前液体量、变为低体温前输注的血液、到达时脉搏和收缩压、暴露于低体温或正常体温的时间)显示,体温低于36.0°C时每降低1°C,24小时红细胞消耗增加10%(发生率比0.90,95%CI 0.89-0.92,p<0.00)。
  • 体温高于36°C时,红细胞给药与体温无关联。
  • 入院低体温是死亡的独立预测因素:24小时死亡调整OR 2.7(95%CI 1.7-4.5,p<0.00),30天死亡调整OR 1.8(95%CI 1.3-2.4,p<0.00)。

证据类型、等级与局限

  • 证据类型:PROPPR试验的二次分析(预后研究),证据等级为预后 level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现支持在创伤患者中维持正常体温。
  • 作者建议,需进一步研究大量输血期间降温或复温的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hypothermia is associated with poor outcomes after injury. The relationship between hypothermia during contemporary large volume resuscitation and blood product consumption is unknown. We evaluated this association, and the predictive value of hypothermia on mortality.

METHODS: Patients predicted to receive massive transfusion at 12 level 1 trauma centers were randomized in the Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) trial and were grouped into those who were hypothermic (<36°C) or normothermic (36-38.5°C) within the first 6 hours of emergency department arrival. The impact of hypothermia or normothermia on the volume of blood product required during the first 24 hours was determined via negative binomial regression, adjusting for treatment arm, injury severity score, mechanism, demographics, pre-emergency department fluid volume, blood administered before becoming hypothermic, pulse and systolic blood pressure on arrival, and the time exposed to hypothermic or normothermic temperatures.

RESULTS: Of 680 patients, 590 had a temperature measured during the first 6 hours in hospital, and 399 experienced hypothermia. The mean number of red blood cell (RBC) units given to all patients in the first 24 hours of admission was 8.8 (95% confidence interval [CI], 7.9-9.6). In multivariable analysis, every 1°C decrease in temperature below 36.0°C was associated with a 10% increase (incidence rate ratio, 0.90; 95% CI, 0.89-0.92; p < 0.00) in consumption of RBCs during the first 24 hours of admission. There was no association between RBC administration and a temperature above 36°C. Hypothermia on arrival was an independent predictor of mortality, with an adjusted odds ratio of 2.7 (95% CI, 1.7-4.5; p < 0.00) for 24-hour mortality and 1.8 (95% CI, 1.3-2.4; p < 0.00) for 30-day mortality.

CONCLUSION: Hypothermia is associated with increase in blood product consumption and mortality. These findings support the maintenance of normothermia in trauma patients and suggest that further investigation on the impact of cooling or rewarming during massive transfusion is warranted.

LEVEL OF EVIDENCE: Prognostic, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Lester ELW, Fox EE, Holcomb JB, et al. The impact of hypothermia on outcomes in massively transfused patients. J Trauma Acute Care Surg. 2019. PMID: 30444856. doi:10.1097/TA.0000000000002144

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。